Telomir Pharmaceuticals, Inc. (TELO) Q1 2024 Earnings
TELO·Reported May 13, 2024·Before market open
Diluted EPS came in at $-0.23.
Diluted EPS
$-0.23
Financial Snapshot
Trailing eight quarters through Q1 2024
Q1 2024 Earnings FAQ
Common questions about Telomir Pharmaceuticals, Inc.'s Q1 2024 earnings report.
Telomir Pharmaceuticals, Inc. (TELO) reported Q1 2024 earnings on May 13, 2024 before market open.
Telomir Pharmaceuticals, Inc. reported diluted EPS of $-0.23 for Q1 2024.
You can read the 10-Q periodic report (0001493152-24-018909) directly on SEC EDGAR. The filing index links above go to sec.gov.